Seven weeks before Merck &amp; Co. pulled the arthritis drug Vioxx off the market because of safety concerns, federal drug regulators downplayed the significance of scientific findings citing the increased risks, documents released Thursday show.
The European Medicines Agency said Friday it has been asked by the European Commission to conduct a review of certain arthritis drugs following the worldwide withdrawal of Merck &amp; Co.'s Vioxx medication.
Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.
